Evidence map›Paper›PMID 37213759›Full record

ArticlePEC innovation2022

Treatment goals in IBD: A perspective from patients and their partners.

Niene M S Peek-Kuijt, Margaretha J Aantjes, Marthe Verwey, Leti Van Bodegom-Vos, Andrea E van der Meulen-de Jong, Jeroen P W Maljaars

Abstract read
In one paragraph

Article in PEC innovation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Niene M S Peek-KuijtLeiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands.
Margaretha J AantjesLeiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands.
Marthe VerweyLeiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands.
Leti Van Bodegom-VosLeiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands.
Andrea E van der Meulen-de JongLeiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands.
Jeroen P W MaljaarsLeiden University Medical Centre, Department of Gastroenterology and Hepatology, Leiden, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To identify and compare treatment goals between IBD patients and partners, and how these change upon receiving information. Methods: During a patient information day a self-made survey was distributed before and after a lecture about a physicians' view on treatments goals. Patients and partners were asked for their preferred treatment goals at 6 weeks and at 6 months and could choose between short-term goals (symptom free, improved functioning, better QOL, normal colonoscopy) and long-term goals (prevention of surgery, complications, flares and no steroids). Results: Being "symptom-free" (55.9%) was the preferred goal. Patients with higher disease activity chose more short-term goals (p=0.03) at 6 weeks. Age, gender and education did not affect treatment goals. Partners chose more short-term goals (p=0.03) at 6 weeks. Post-lecture, answers shifter to normal colonoscopy (4.2% versus 18.0%, p=0.001), and a better QOL (21.2% vs 33.3%, p=0.039) as goal at 6-months. Conclusions: Patients' 6-week treatment goals focused on being symptom-free and having a high QOL, especially those patients with high disease activity. Partners chose more short-term goals than patients at 6 weeks. Innovation: General health information can be applied and translated into treatment goals. This may assist in remote shared goal setting and decision making.

Indexed as

inflammatory bowel diseasepatient- physician communicationpatient preferencestreatment goals

Identifiers

PMID37213759
PMCPMC10194327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.